- Home
- LADR vs IMTX Comparison
LADR vs IMTX Comparison
Compare LADR & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LADR | IMTX |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | Germany |
| Employees | N/A | 407 |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | LADR | IMTX |
|---|---|---|
| Price | $9.78 | $10.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | $12.75 | ★ $19.00 |
| AVG Volume (30 Days) | ★ 763.3K | 491.1K |
| Earning Date | 04-23-2026 | 05-12-2026 |
| Dividend Yield | ★ 9.41% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.51 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $31.66 | N/A |
| Revenue Next Year | $19.12 | $45.15 |
| P/E Ratio | $19.18 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.61 | $3.30 |
| 52 Week High | $11.92 | $12.41 |
Technical Indicators
Market Signals| Indicator | LADR | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 39.14 | 58.06 |
| Support Level | N/A | $9.05 |
| Resistance Level | $11.37 | $10.64 |
| Average True Range (ATR) | 0.18 | 0.53 |
| MACD | -0.00 | 0.07 |
| Stochastic Oscillator | 29.31 | 80.00 |
Price Performance
Historical ComparisonAbout LADR Ladder Capital Corp
Ladder Capital Corp is an internally-managed real estate investment trust that is in commercial real estate finance. The company originates and invests in a diverse portfolio of commercial real estate and real estate-related assets, focusing on senior secured assets. The company's investment activities include: (i) Primary business of originating senior first mortgage fixed and floating rate loans collateralized by commercial real estate with flexible loan structures; (ii) owning and operating commercial real estate, including net leased commercial properties; and (iii) investing in investment-grade securities secured by first mortgage loans on commercial real estate. The company has three reportable segments: Loans, which derive maximum revenue; Securities; and Real Estate.
About IMTX Immatics N.V.
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.